Trial intelligence / Profile preview

LiBiDi lithium multimodal imaging study in bipolar disorder

2012-000778-46Phase 4Active

Sponsor
Forschungszentrum Jülich
Start
Jul 2012
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of lithium carbonate in bipolar I disorder (3 arms), sponsored by Forschungszentrum Jülich. Started Jul 2012; status: active.

02

Drugs

lithium carbonate
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on 2012-000778-46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-000778-46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call